TNF activates NF-κB by phosphatidylcholine-specific phospholipase C-induced "Acidic" sphingomyelin breakdown

Cell

Volumn 71, Issue 5, 1992, Pages 765-776

  Schütze, Stefan ^a   Potthoff, Karin ^a   Machleidt, Thomas ^a   Berkovic, Dinko ^b   Wiegmann, Katja ^a   Krönke, Martin ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; PHOSPHATIDYLCHOLINE; PHOSPHOLIPASE C; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR;

ARTICLE; CELL STIMULATION; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVATION; ENZYME ASSAY; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE REPRESSION; HUMAN; HUMAN CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RECEPTOR BINDING; SIGNAL TRANSDUCTION; T LYMPHOCYTE; THIN LAYER CHROMATOGRAPHY; TRANSCRIPTION INITIATION;

BASE SEQUENCE; CERAMIDES; DIGLYCERIDES; ISOELECTRIC POINT; MOLECULAR SEQUENCE DATA; NF-KAPPA B; OLIGODEOXYRIBONUCLEOTIDES; PHOSPHATIDYLCHOLINES; PHOSPHOLIPASE C; RECEPTORS, CELL SURFACE; RECEPTORS, TUMOR NECROSIS FACTOR; REGULATORY SEQUENCES, NUCLEIC ACID; SIGNAL TRANSDUCTION; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOMYELINS; SUPPORT, NON-U.S. GOV'T; TUMOR NECROSIS FACTOR;

EID: 0026458406     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/0092-8674(92)90553-O     Document Type: Article

References (72)

1. A protein kinase C pseudosubstrate peptide inhibits phosphorylation of the CD3 antigen in streptolysin-O permeabilized human T lymphocytes
2. Human tumour necrosis factor-alpha (TNF-alpha) directly stimulates arachidonic acid release in human neutrophils
3. The inducible transcription factor NF-κB: regulation by distinct protein subunits
4. Activation of DNA-binding activity in an apparently cytoplasmatic precursor of the NF-κB transcription factor
5. I-κB: a specific inhibitor of the NF-κB transcription factor
6. A 65-kd subunit of active NF-κB is required for inhibition of NF-κB by I-κB
7. The v-rel oncogene encodes a κB enhancer binding protein that inhibits NF-κB function
8. Tumor necrosis, cachexia, shock and inflammation: a common mediator
9. NF-κB and related proteins: Rel/dorsal homologies meet ankyrin-like repeats
10. A rapid method of total lipid extraction
11. Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity
12. Neutral sphingomyelinase from human urine. Purification and preparation of monospecific antibodies
13. 2-activating protein in endothelial cells
14. Evidence that neutral sphingomyelinase of cultured murine neuroblastoma cells is orientated externally on the plasma membrane
15. Activation of jun B by PKC and PKA signal transduction through a novel cis-acting element
16. Tumor necrosis factor-α activates the sphingomyelin signal transduction pathway in a cell free system
17. Tumor necrosis factor α activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF kappa B sites in the long terminal repeat
18. A new sensitive determination of phosphate
19. The dephosphorylation of insulin and epidermal growth factor receptors: role of endosome-associated phosphotyrosine phosphatase(s)
20. Molecular basis of acid sphingomyelinase deficiency in a patient with Niemann-Pick disease type A
21. NF-κB, KBF1, dorsal, and related matters
22. Recombinant tumor necrosis factor and interleukin 1 both stimulate human synovial cell arachidonic acid release and phospholipid metabolism
23. Molecular cloning and expression of the type 1 and type 2 murine receptors for tumor necrosis factor
24. Activation in vitro of NF-κB by phosphorylation of its inhibitor IκB
25. Cloning of the p50 DNA binding subunit of NF-κB: homology to rel and dorsal
26. Functions of sphingolipids and sphingolipid breakdown products in cellular regulation
27. Molecular cloning and expression of human and rat tumor necrosis factor receptor chain (p60) and its soluble derivative, tumor necrosis factor-binding protein
28. Maintenance of NF-kappa B activity dependent on protein synthesis and the continuous presence of external stimuli
29. TNF stimulates expression of mouse MHC class I genes by inducing an NF-κB like enhancer binding activity which displaces constitutive factors
30. Identification and purification of the human immunoglobulin-enhancer binding protein (NF-kappa B) that activates transcription from a human immunodeficiency virus type 1 promotor in vitro
31. Epidermal growth factor receptor kinase translocation and activation in vivo
32. Internalization and activation of the rat liver insulin receptor kinase in vivo
33. The DNA binding subunit of NF-κB is identical to factor KBF1 and homologous to the rel oncogene product
34. Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor α and κ-interferon
35. 1,2-Diacylglycerols but not phorbol ester stimulate sphingomyelin hydrolysis in GH3 pituitary cells
36. 1,2-Diacylglycerols and phorbolesters stimulate phosphatidylcholine metabolism in GH3 pituitary cells
37. 1,2-Diacylglycerols, but not phorbol esters, activate a potential inhibitory pathway for protein kinase C in GH3 pituitary cells
38. The preparation of phospholipids by phospholipase D
39. TNF signal transduction and TNF responsive genes
40. Inhibition of tumor necrosis factor (TNF) mediated NF-κB activation by selective blockade of the human 55-kd TNF receptor
41. Biology of disease. Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities
42. NF-kappa B protein purification from bovine spleen: nucleotide stimulation and binding site specificity
43. NF-κB a pleiotropic mediator of inducible and tissue-specific gene control
44. Niemann-Pick disease: a frequent missense mutation in the acid sphingomyelinase gene of Ashkenazi Jewish type A and B patients
45. Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific
46. Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor
47. Tumor necrosis factor alpha induces proteins that bind specifically to kappa B-like enhancer elements and regulate interleukin 2 receptor α chain gene expression in primary human T lymphocytes
48. Characterization of a ceramide-activated protein kinase: stimulation by tumor necrosis factor α
49. Protein kinase C-independent activation of nuclear factor κB by tumor necrosis factor
50. Acidification of the endocytic and exocytic pathways
51. NF-kappa B: a family of inducible and differentially expressed enhancer-binding proteins in human T cells
52. Interruption of TPA-induced signals by an antiviral and antitumoral xanthate compound: inhibition of a phospholipase C-type reaction
53. Coomassie brilliant blue staining of lipids on thin layer plates
54. Tumor necrosis factor polypeptide mediator network
55. Tumor necrosis factor α and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor κB
56. Acid sphingomyelinase from human urine: purification and characterization
57. Sphingomyelinase activity at pH 7.4 in human brain and a comparison to activity at pH 5.0
58. New form of acid phosphatase during lysosome biogenesis
59. Isolation of a rel-related human cDNA that potentially encodes the 65-kd subunit of NF-κB
60. Quantitation of hexadecylphosphocholine by high performance thin layer chromatography with densitometry
61. Molecular cloning and expression of a receptor for human tumor necrosis factor
62. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1
63. Isolation, nucleotide sequence, and expression of the full-length and alternatively spliced cDNAs
64. Tumor necrosis factor signal transduction. Cell-type-specific activation and translocation of protein kinase C
65. Tumor necrosis factor induces rapid production of 1,2-diacylglycerol by a phosphatidylcholine-specific phospholipase C
66. Inducibility of κ immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism
67. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins
68. Secondary structure of sphingomyelinase from Bacillus cereus
69. Interaction of growth factor receptors with the cytoskeleton is related to receptor clustering
70. Human 55 kD receptor for tumor necrosis factor coupled to signal transduction cascades
71. Purified human IκB can rapidly dissociate the complex of the NF-κB transcription factor with its cognate DNA
72. Purification to homogeneity of human placental acid sphingomyelinase